What is she best known for?
The fields of study she is best known for:
- Gene
- Immune system
- Cytokine
Her primary areas of investigation include Cell biology, Immunology, Receptor, Microglia and TREM2.
Her Cell biology research integrates issues from Natural killer T cell, Interleukin 21, Janus kinase 3, Antigen-presenting cell and Natural killer cell.
Her studies in Innate lymphoid cell, Interferon, Immune system, Autoimmunity and T lymphocyte are all subfields of Immunology research.
Her Receptor research includes themes of Cytokine, Molecular biology, Gene, Lymphocyte and Oligodendrocyte.
Her work carried out in the field of Microglia brings together such families of science as Myelin, Phagocytosis, Neurodegeneration and Homeostasis.
Her studies deal with areas such as Cell survival, Disease, Neuroscience and Lipid sensing as well as TREM2.
Her most cited work include:
- Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus (977 citations)
- TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model (725 citations)
- Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1 (710 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Cell biology, Immunology, Receptor, Innate lymphoid cell and Molecular biology.
Her Cell biology research incorporates elements of Interleukin 21, Microglia and Cellular differentiation.
The Interleukin 21 study combines topics in areas such as NKG2D and Interleukin 12.
Her Receptor study integrates concerns from other disciplines, such as Cytokine, CD226, Antigen, TREM2 and Intracellular.
Susan Gilfillan interconnects RAR-related orphan receptor gamma, Transcription factor and Effector in the investigation of issues within Innate lymphoid cell.
Her research investigates the connection between Molecular biology and topics such as T-cell receptor that intersect with issues in Null allele.
She most often published in these fields:
- Cell biology (43.69%)
- Immunology (38.83%)
- Receptor (31.07%)
What were the highlights of her more recent work (between 2017-2021)?
- Cell biology (43.69%)
- Innate lymphoid cell (15.53%)
- Receptor (31.07%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Cell biology, Innate lymphoid cell, Receptor, TREM2 and Microglia.
Her research integrates issues of In vitro, Transcription factor, NFIL3, Dendritic cell and In vivo in her study of Cell biology.
Susan Gilfillan's looking at Innate lymphoid cell as part of her Immunology and Immune system and Innate lymphoid cell study.
Her Immunology research is multidisciplinary, incorporating elements of Progenitor cell and Severe combined immunodeficiency.
Her study in Immune system is interdisciplinary in nature, drawing from both Molecular biology and Gastrointestinal tract.
Susan Gilfillan combines subjects such as Cancer research and Immunotherapy with her study of Receptor.
Between 2017 and 2021, her most popular works were:
- Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (139 citations)
- Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. (102 citations)
- Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues. (53 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cytokine
Susan Gilfillan spends much of her time researching Cell biology, Receptor, TREM2, In vitro and Population.
Her Cell biology research is multidisciplinary, incorporating perspectives in Cytokine and Innate lymphoid cell.
The concepts of her Innate lymphoid cell study are interwoven with issues in Tumor necrosis factor alpha, RAR-related orphan receptor gamma and Effector.
The various areas that Susan Gilfillan examines in her Receptor study include Cancer and Immunotherapy.
Her TREM2 study results in a more complete grasp of Microglia.
Her In vitro research is multidisciplinary, relying on both Transgene, RNA, Transcription factor, Chromatin and In vivo.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
